- BNF:
- 13.10.2
- Status:
- Do Not Prescribe (DNP)
- Decision Date:
- February 2014
Comments
GREY:1,5,7 Amorolfine is the preferred topical treatment in fungal nail infections with restricted use.
Do Not Prescribe (DNP) Drug Classifications
- 1: Are classified by the BNF as 'less suitable for prescribing', and includes anti-malarials (where a private prescription may be provided). Have a lack of data on effectiveness compared with standard therapy
- 5: Less cost-effective than current standard therapy
- 7: Those that are deemed by national publications (e.g. by NHSE/ NHS Clinical Commissioners) of limited value, unless agreed by local agreement
search again